Key result
L-NAME selectively decreased NMDA-induced CA1 lesions in rats but had no effect on AMPA toxicity or ischaemia-induced hippocampal damage.
Nitric oxide contributes to NMDA toxicity, but NO synthase inhibition does not protect against ischaemia-induced hippocampal lesions in this model.
Answers are grounded in this paper and cite their sources.
NO synthase inhibition may selectively target NMDA toxicity in rats; leaves open translation to ischaemic neuroprotection.
We assessed the effect of NG-Nitro-L-arginine methylester (L-NAME), an inhibitor of nitric oxide synthase, on the hippocampal lesions induced either by the focal injection of N-methyl-D-aspartate (NMDA) or (s)-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (s-AMPA) or by 10 min of severe forebrain ischaemia (4-vessel occlusion), in the rat. We find that L-NAME, 20 or 40 mg kg-1, selectively decreases NMDA-induced CA1 lesions while it has no effect on AMPA toxicity. L-NAME, 20 mg kg-1, does not decrease hippocampal damage induced by ischaemia. These results suggest that NO contributes to NMDA toxicity and support data indicating that NMDA receptor antagonists fail to protect against hippocampal CA1 lesions in the 4-vessel occlusion model.
No takes yet. Share an insight, caveat, or question.
Moncada et al. (1992) studied Hippocampal lesions (NMDA-, AMPA-, or ischaemia-induced). NG-Nitro-L-arginine methylester (L-NAME) was evaluated on Hippocampal lesions. L-NAME selectively decreased NMDA-induced CA1 lesions in rats but had no effect on AMPA toxicity or ischaemia-induced hippocampal damage.
Synapse has enriched 10 related papers. Consider them for comparative context: